PHARMACOKINETICS-PHARMACODYNAMICS OF
ANTICANCER DRUGS: RESISTANCES AND SYNERGIES

PARIS, CORDELIERS RESEARCH CENTRE, DECEMBER 18-19, 2008: REGISTERED PARTICIPANTS
Registered participants, as of December 15, 2008

  1. Annabelle Ballesta, INRIA Paris-Rocquencourt, France

  2. Jacques Bélair, Université de Montréal, Montréal, QC, Canada

  3. Assia Benabdallah, Université de Provence, Marseille, France

  4. Sébastien Benzekry, Université de Provence, Marseille, France

  5. Samuel Bernard, CNRS, Lyon, France

  6. Justine Bodin, Université Claude Bernard, Lyon, France

  7. Frédéric Bonnans, INRIA Saclay-Ile-de-France, France

  8. Catherine Bonnet, INRIA Saclay-Ile-de-France, France

  9. Radomir Chabiniok, INRIA Paris-Rocquencourt, France

  10. Jean Clairambault, INRIA Paris-Rocquencourt, France

  11. Fabien Crauste, CNRS, Lyon, France

  12. Dinesh DeAlwis, Eli Lilly, UK

  13. Ivan Demin, Université Claude Bernard, Lyon, France

  14. Alessandro De Toni, Università degli studi di Padova, Italy

  15. Sophie Dimicoli, Hôtel-Dieu, APHP, Paris, France

  16. Marie Doumic-Jauffret, INRIA Paris-Rocquencourt, France

  17. Sandrine Dulong, INSERM U 776, Villejuif, France

  18. Roland Fisch, Novartis, Basel, CH

  19. Claude Gérard, Université Libre de Bruxelles, Brussels, Belgium

  20. Jean-Charles Gilbert, INRIA Paris-Rocquencourt, France

  21. Albert Goldbeter, Université Libre de Bruxelles, Brussels, Belgium

  22. Domitille Heitzler, INRIA Paris-Rocquencourt, France

  23. Marie Henry, Université de Provence, Marseille, France

  24. Peter Hinow, University of Minnesota, Minneapolis, MN, USA

  25. Pasquale Innominato, INSERM U 776, Villejuif, France

  26. Raphaël Itzykson, CHRU Lille & INSERM 837, Lille, France

  27. Peter Kim, University of Utah, Salt Lake City, UT, USA

  28. Serge Larrivière, Université Paris VIII, France

  29. Thomas Lepoutre, INRIA Paris-Rocquencourt, France

  30. Francis Lévi, INSERM U 776, Villejuif, France

  31. Pierre Magal, Université du Havre, France

  32. Jean-Pierre Marie, INSERM U 872 & Hôtel-Dieu, APHP, Paris, France

  33. Inès Paule, Université Claude Bernard, Lyon, France

  34. Benoît Perthame, Université Pierre-et-Marie-Curie, Paris, France

  35. Ghazi Qassa, Hôtel-Dieu, APHP, Paris, France

  36. Vito Quaranta, Vanderbilt University, Nashville, TN, USA

  37. Abdel Rabhi, Institut Gustave Roussy, Villejuif, France

  38. Benjamin Ribba, INRIA Rhône-Alpes, Lyon, France

  39. Bernard Rio, Hôtel-Dieu, APHP, Paris, France

  40. Marina Savelieva Praz, Novartis, Basel, CH

  41. Jeannette Soria, INSERM U 872, Paris, France

  42. Jan Stuchlý, Charles University, Prague, Czech Republic

  43. Pierre Sujobert, CHU Pitié-Salpêtrière, Paris, France

  44. Maciej Swat, SYMCYP, UK

  45. Andrzej Swierniak, Silesian University of Technology, Gliwice, Poland

  46. Jack Tuszynski, University of Alberta, Edmonton, Alberta, Canada

  47. Vladimir Vainstein, IMBM and Department of Haematology, Hadassah Medical Centre, Jerusalem, Israel

  48. Julio Vera, University of Rostock, Rostock, Germany

  49. Federico Verga, Université de Provence, Marseille, France

  50. Alissa Weaver, Vanderbilt University, Nashville, TN, USA

  51. Jorge Zubelli, IMPA, Rio de Janeiro, Brazil

Back to the workshop homepage